Peripheral Nerve Disease
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Neuroprotection of Memantine and Rosuvastatin
Turkish Adaptation of the CTS-6 Evaluation Tool: A Validation and Reliability Study
"Ultrasound Measures and Clinical Outcomes in Healthy Individuals, Mild and Moderate Carpal Tunnel Syndrome Patients"
The Development of Diagnosis and Prognosis Predictive Model for Peripheral Nerve Disease
Innervation Characteristics and Determination of Nerve Entry Points of the Musculus Semispinalis Capitis
Effect of Ankle-foot Orthoses on Balance Confidence
Sensory Reeducation in Peripheral Nerve Injuries of Hand